Project Grant R43DA064245
Award Date 6/15/26
Completion Date 5/31/27
Dollars Obligated $399K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse awarded $314,109 to Behavior Change Hub LLC on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop the Addiction Application Gradebook, a web-based platform for evaluating and assessing smartphone and web applications targeting substance use disorder (SUD). This Phase One Small Business Technology Transfer (STTR) project will establish foundational research and development across three key...
- Federal Grant Award Summary Addinex Technologies, Inc. received a $613,056 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop an enhanced medication adherence and monitoring system for decentralized clinical trials in substance use disorder (SUD) treatment. The award, effective September 1, 2025 through August 31, 2026, funds the adaptation of Addinex's existing medication management platform to enable...
- Federal Grant Award Summary Partnership To End Addiction received a $453,750 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 15, 2026, through February 29, 2028. The award funds development and evaluation of HALO (Helping Affected Loved Ones), an artificial intelligence-powered chatbot designed to deliver evidence-based, real-time support to concerned significant others (CSOs)—primarily parents...
- Federal Grant Award Summary Carina Medical LLC received a $304,215 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025 and concluding July 31, 2026. The awardee is developing and validating a novel software platform designed to enable decentralized clinical trials (DCTs) for substance use disorder (SUD) research, with integration of large language models (LLMs). This platform addresses significant...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UCLA a $376,398 Project Grant effective April 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate a digital therapeutic intervention for individuals with comorbid anxiety disorders and alcohol/cannabis use disorders. The primary deliverable is Anxiety Management Treatment for Substance Use Disorders (AMT/SUD), a mobile application-based intervention that adapts...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $235,500 Project Grant on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of California, Irvine to develop, refine, field test, and deploy an artificial intelligence-based chatbot designed to enhance engagement in mobile peer-to-peer support groups for smoking cessation and tobacco addiction treatment. The chatbot, built on a state-of-the-art large language...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $1,091,599 to the Research Foundation For Mental Hygiene, Inc. (through the New York State Psychiatric Institute) on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test E-ConnectYA, a system-level intervention tailored for criminal legal system-involved young adults (YACL). The project addresses elevated rates of overdose, suicide, and substance use and mental health...
- Federal Grant Award Summary Biosyft Inc. received a $301,390 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective July 1, 2026, through June 30, 2027. The company is developing and validating an artificial intelligence (AI)-driven behavioral analysis platform designed to detect addiction-related reward signatures in rodent models through automated multi-view analysis. The platform addresses critical...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Columbia University's Health Sciences Division a $777,565 Project Grant on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop evidence-based, personalized treatment protocols for opioid use disorder (MOUD). The project will utilize data fusion methodology to synthesize information from seven large MOUD trials conducted by the NIDA Clinical Trials Network, generating quantitative...
- Federal Grant Award Summary Pillsmart Inc. received a $399,993 Phase I Small Business Innovation Research (SBIR) project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 1, 2026 through May 31, 2027. The company is developing LEVL, a clinical decision support (CDS) system designed to enable early detection of relapse risk among adolescents with substance use disorders (SUDs). The platform integrates...